A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

被引:5
作者
Schmucker, Christine [1 ]
Antes, Gerd [1 ]
Lelgemann, Monika [2 ]
机构
[1] Univ Med Ctr Freiburg, German Cochrane Ctr, Freiburg, Germany
[2] Univ Bremen, Hlth Technol Assessment Ctr, Bremen, Germany
关键词
Age-related macular degeneration; Bevacizumab; Efficacy; Safety; VERTEPORFIN PHOTODYNAMIC THERAPY; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB; SAFETY;
D O I
10.1007/s00417-009-1249-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:451 / 452
页数:2
相关论文
共 11 条
  • [1] Intravitreal bevacizumab vs verteporfin photodynamic therapy for Neovascular age-related macular degeneration
    Bashshur, Ziad F.
    Schakal, Alexandre
    Hamam, Rola N.
    El Haibi, Christelle P.
    Jaafar, Rola F.
    Noureddin, Baha' N.
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (10) : 1357 - 1361
  • [2] Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
    Brown, David M.
    Michels, Mark
    Kaiser, Peter K.
    Heier, Jeffrey S.
    Sy, Judy P.
    Ianchulev, Tsontcho
    [J]. OPHTHALMOLOGY, 2009, 116 (01) : 57 - 65
  • [3] The International Intravitreal Bevacizumab Safety Survey: using the Internet to assess drug safety worldwide
    Fung, A. E.
    Rosenfeld, P. J.
    Reichel, E.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (11) : 1344 - 1349
  • [4] Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration
    Hahn, R.
    Sacu, S.
    Michels, S.
    Varga, A.
    Weigert, G.
    Geitzenauer, W.
    Vecsei-Marlovits, P.
    Schmidt-Erfurth, U.
    [J]. OPHTHALMOLOGE, 2007, 104 (07): : 588 - 593
  • [5] Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (01) : 68 - 73
  • [6] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) : 1419 - 1431
  • [7] Twelve-month safety of intravitreal injections of bevacizumab (Avastin®):: results of the Pan-American Collaborative Retina Study Group (PACORES)
    Wu, Lihteh
    Martinez-Castellanos, Maria A.
    Quiroz-Mercado, Hugo
    Arevalo, J. Fernando
    Berrocal, Maria H.
    Farah, Michel E.
    Maia, Mauricio
    Roca, Jose A.
    Rodriguez, Francisco J.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (01) : 81 - 87
  • [8] CATT STUDY
  • [9] EQUAL STUDY
  • [10] IVAN STUDY